deltatrials
Completed OBSERVATIONAL NCT03601013

Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey

Sponsor: Cardiovascular Academy Society, Turkey

Updated 6 times since 2018 Last updated: May 6, 2019 Started: Mar 1, 2018 Primary completion: Nov 1, 2018 Completion: Mar 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03601013, this observational or N/A phase trial focuses on Anti-platelet Therapy and remains completed. Sponsored by Cardiovascular Academy Society, Turkey, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2018 – ~Jun 2019 · 10 months · monthly snapshotRecruiting~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jun 2019 — Jan 2021 [monthly]

    Completed

    Status: RecruitingCompleted

Show 1 earlier version
  1. Aug 2018 — Jun 2019 [monthly]

    Recruiting

    First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardiovascular Academy Society, Turkey
Data source: Cardiovascular Academy Society, Turkey

For direct contact, visit the study record on ClinicalTrials.gov .